Moving from lymph node metastasis in gastric cancer to biological markers

World Journal of Surgery

Volumn 34, Issue 5, 2010, Pages 1140-1141

  Fatourou, E ^a   Ziogas, D ^b   Baltogiannis, G ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER INVASION; CANCER STAGING; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NOTE; PATHOLOGY; STOMACH TUMOR;

HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954691131     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0368-9     Document Type: Letter

References (10)

1. Fukuda N, Sugiyama Y, Mimdorikawa A et al (2009) Prognostic significance of the metastatic lymph node ratio in gastric cancer patients. World J Surg 33(11):2378-2382
2. Roukos DH (2009) Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol 16(4):795-798
3. Roukos DH, Paraschou P, Lorenz M (2000) Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7(10):719-726
4. Roukos DH (2009) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol. doi:10.1245/s10434-009-0766-0
5. Roukos DH (2009) Mea culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev Mol Diagn 9(3):217-221
6. Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9(10):1413-1416
7. Roukos DH (2009) Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn 9(3):227-229
8. Roukos DH (2009) Genomewide association studies: how predictable is a person's cancer risk? Expert Rev Anticancer Ther 9(4):389-392
9. Roukos DH (2009) Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer. J Clin Oncol 27(8):1337-1338
10. Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33-48